Is NCT07370584 recruiting in Memphis, TN?

Yes, NCT07370584 is currently recruiting participants at its Memphis, TN location. This safety study clinical trial is actively enrolling qualified participants.

How do I join the safety study clinical trial in Memphis?

To join this clinical trial in Memphis, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Memphis clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Safety Study Clinical Trial in Memphis, TN

About This Safety Study Study in Memphis

The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.

Sponsor: iVeena Delivery Systems, Inc.

Who Can Participate

Inclusion Criteria

Subjects who meet all the following inclusion criteria at Visit 1 will be eligible to enroll in the study. Ocular criteria apply to both eyes.

Age 18-49. -

Ability to voluntarily provide written informed consent. -

Being clinically healthy, as determined by the investigator. -

Willing and able to comply with clinic visits and study-related procedures. -

Willing and able to discontinue use of topical ocular medications, unless approved by investigator. Note: Artificial tears are allowed but must not be used within 30 minutes before or after administration of the study investigational product (IP). -

BCVA better than or equal to 0.2 logarithm of the minimum angle of resolution (logMAR) (20/30 Snellen equivalent). -

Corneal thickness 450 to 670 μm. -

Intraocular pressure (IOP) ≤22 mmHg. -

Willingness to not wear mascara for 6 weeks of the study. -

Willingness to not swim in an indoor pool for 6 weeks of the study. -

Exclusion Criteria

Subjects who meet any of the following criteria at Visit 1 will not be eligible to enroll in the study. Ocular criteria apply to either eye.

Participation in a clinical trial with the use of any investigational drug or treatment within 30 days prior to Visit 1 and duration of the study. -

Known copper allergy, sensitivity, or processing disorder (e.g., Wilson's disease). -

Presence of significant central corneal scarring or hydrops. -

History or presence of punctal stenosis or bloody discharge. -

History of or presence of nasolacrimal duct occlusion, nasolacrimal system trauma, nasolacrimal or eyelid cancer, ectropion or entropion, dacryocystitis, dacryoadenitis, chronic conjunctivitis, recurrent subconjunctival hemorrhage, trichiasis, distichiasis, or uncontrolled dry eye. -

Previous cornea, glaucoma, eyelid, strabismus (exotropia or esotropia), or intraocular surgeries. -

Current or previous ocular disorder, including but not limited to: strabismus (exotropia or esotropia), amblyopia, glaucoma, macular degeneration, cataract, retinal detachment or nystagmus, or abnormality of the central cornea, lens, iris, ciliary body, or central retina. -

Presence of any medical condition predisposing the subject to craniofacial anomalies, degenerative myopia, or abnormal ocular refractive anatomy (e.g., osteogenesis imperfecta or Stickler, Down, Ehlers-Danlos, Donnai-Barrow, Treacher-Collins, or Apert/Crouzon/ Pfeiffer syndrome). -

Active or recent (within 2 weeks prior to screening) bacterial, viral, or allergic conjunctivitis. -

Active allergies causing uncontrolled ocular and nasal symptoms. -

Active sinusitis. -

Current or previous hypothyroidism or hyperthyroidism. -

Ongoing or recent (within 3 months prior to screening) chronic use of eyedrops containing preservatives such as benzalkonium chloride (BAK), Purite, or Polyquad. -

History of uncontrolled gastroenteric reflux disease or deviated nasal septum. -

If a female of childbearing potential (FOCBP):

Are pregnant or lactating.

Are unwilling to use an effective form of contraception (e.g., hormonal, oral, transdermal, implant, injection, or abstinence) for the duration of the study. -

A male subject with a partner who is a FOCBP unwilling to use an effective form of contraceptives (e.g., barrier, hormonal, oral, transdermal, implant, injection, or abstinence) for either themselves or their partner, as appropriate, for the duration of the study. -

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Memphis?

Yes, this clinical trial (NCT07370584) has an active research site in Memphis, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Safety Study Treatment Options in Memphis, TN

If you're searching for safety study treatment options in Memphis, TN, this clinical trial (NCT07370584) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Memphis research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced safety study specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all safety study clinical trials near you to find additional studies recruiting in your area.

Safety Study Clinical Trial in Memphis, TN

Expert Care in Memphis

IRB Approved

No-Cost Care

Apply for This Memphis Location

Why Participate?

Simple Process